ACOG Alpha Cognition Inc.

NASDAQ
$8.84

Alpha Cognition Inc. (ACOG) is expected to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is a loss of $0.32 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -5.4% since its last earnings release on August 13, 2026.

Alpha Cognition Missed Consensus Estimates
Thursday, August 13, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · 4:15 PM ET
Earnings Whisper
-
vs ($0.32)
Rev est $6.47M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $8.84

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Alpha Cognition Inc.

Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (“mTBI”), for which there are currently no approved treatment options.

Sector

Healthcare

Industry

Biotechnology